|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.843
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.740
|
|
|
|
natural killer cell degranulation
|
GO:0043320 |
3 |
0.712
|
|
|
|
natural killer cell activation involved in immune response
|
GO:0002323 |
10 |
0.698
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.693
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.638
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.636
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.606
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.558
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.447
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.441
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.431
|
|
|
|
membrane protein proteolysis
|
GO:0033619 |
10 |
0.428
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.379
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.364
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.359
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.350
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.333
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.333
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.321
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.295
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.282
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.266
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.266
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.256
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.250
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.234
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.212
|
Human |
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.204
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.202
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.198
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.194
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.182
|
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.177
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.171
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.166
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.165
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.163
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.163
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.159
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.152
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.148
|
|
|
|
glycosphingolipid catabolic process
|
GO:0046479 |
5 |
0.137
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.134
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.132
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.131
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.131
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.130
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.130
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.130
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.125
|
|
|
|
peptide hormone processing
|
GO:0016486 |
9 |
0.122
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.121
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.121
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.108
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.108
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.107
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.107
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.105
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.102
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.101
|
|
|
|
positive regulation of natural killer cell mediated immunity
|
GO:0002717 |
16 |
0.101
|
|
|
|
autophagic vacuole assembly
|
GO:0000045 |
13 |
0.099
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.097
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.097
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.095
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.093
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.090
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.090
|
Rat |
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.088
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.082
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.078
|
|
|
|
negative regulation of response to oxidative stress
|
GO:1902883 |
10 |
0.078
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.076
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.074
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.072
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.072
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.071
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.070
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.068
|
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.068
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.068
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.068
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.067
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.066
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.065
|
|
|
|
ceramide catabolic process
|
GO:0046514 |
7 |
0.064
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.063
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.062
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.062
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.062
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.062
|
|
|
|
antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii
|
GO:0002504 |
17 |
0.061
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.061
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.060
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.058
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.058
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.057
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.057
|
|
|
|
glycolipid catabolic process
|
GO:0019377 |
5 |
0.057
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.057
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.056
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.056
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.055
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.055
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.054
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.054
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.054
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.053
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.052
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ii
|
GO:0019886 |
14 |
0.052
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.051
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.050
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.050
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.050
|
|
|
|
macroautophagy
|
GO:0016236 |
21 |
0.050
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.050
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.049
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.049
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.049
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.047
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.046
|
Human |
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.046
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.046
|
Worm |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.045
|
Rat |
|
|
regulation of blood volume by renin angiotensin
|
GO:0002016 |
7 |
0.045
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.045
|
|
|
|
membrane lipid catabolic process
|
GO:0046466 |
8 |
0.045
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.045
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.044
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.044
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.043
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.042
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.041
|
|
|
|
decidualization
|
GO:0046697 |
10 |
0.041
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.041
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.040
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.040
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.039
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.039
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.039
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.039
|
|
|
|
positive regulation of natural killer cell mediated cytotoxicity
|
GO:0045954 |
16 |
0.038
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.037
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.036
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.035
|
Rat |
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.035
|
|
|
|
sphingosine metabolic process
|
GO:0006670 |
4 |
0.035
|
|
|
|
regulation of natural killer cell mediated immunity
|
GO:0002715 |
19 |
0.035
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.035
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.034
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.033
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.032
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class ii
|
GO:0002495 |
17 |
0.032
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.032
|
|
|
|
glycosylceramide metabolic process
|
GO:0006677 |
4 |
0.031
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.031
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.030
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.030
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.030
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.029
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.029
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.029
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.029
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.029
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.028
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.028
|
Rat |
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.028
|
|
|
|
protein stabilization
|
GO:0050821 |
25 |
0.028
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.028
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.028
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.027
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.027
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.027
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.027
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.027
|
Human |
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.026
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.026
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
Human |
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.025
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
33 |
0.025
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.025
|
Worm |
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.025
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.025
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.025
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.025
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.024
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.024
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
28 |
0.024
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.024
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.024
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.024
|
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.024
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.023
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.023
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.023
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.023
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.023
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.022
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.022
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.022
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.022
|
|
|
|
negative regulation of keratinocyte proliferation
|
GO:0010839 |
7 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.022
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.022
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.022
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.022
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.021
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.021
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.021
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.021
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.021
|
Human |
|
|
vacuolar transport
|
GO:0007034 |
11 |
0.021
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.021
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.021
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.020
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.020
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.020
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.020
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.020
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.020
|
|
|
|
lysosomal transport
|
GO:0007041 |
10 |
0.020
|
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
16 |
0.019
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.019
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.019
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.019
|
Rat |
|
|
nerve development
|
GO:0021675 |
67 |
0.019
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.019
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.019
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.019
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.019
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.019
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.018
|
|
|
|
negative regulation of erbb signaling pathway
|
GO:1901185 |
7 |
0.018
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.018
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.018
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.018
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.018
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.018
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.018
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.018
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.017
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
Zebrafish |
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.017
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.017
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.017
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.017
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.016
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.016
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.016
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
regulation of myeloid cell apoptotic process
|
GO:0033032 |
19 |
0.016
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.016
|
|
|
|
negative regulation of cellular response to oxidative stress
|
GO:1900408 |
10 |
0.016
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.016
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.016
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.015
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.015
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.015
|
|
|
|
amyloid precursor protein biosynthetic process
|
GO:0042983 |
3 |
0.015
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.015
|
Human |
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.015
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.015
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.015
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.015
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.015
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.015
|
|
|
|
water soluble vitamin biosynthetic process
|
GO:0042364 |
3 |
0.015
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.014
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.014
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.014
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.014
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.014
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.014
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
15 |
0.014
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
3 |
0.014
|
|
|
|
catagen
|
GO:0042637 |
5 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.014
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.014
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.014
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.013
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.013
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.013
|
|
|
|
sertoli cell differentiation
|
GO:0060008 |
18 |
0.013
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.013
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.013
|
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
19 |
0.013
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.013
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.013
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.013
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.013
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.013
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.013
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.013
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.013
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.013
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.013
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.013
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.013
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.013
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.013
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.013
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.013
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.013
|
|
|
|
notochord cell differentiation
|
GO:0060034 |
1 |
0.012
|
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.012
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.012
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.012
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.012
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.012
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
regulation of leukocyte degranulation
|
GO:0043300 |
20 |
0.012
|
|
|
|
lymphocyte costimulation
|
GO:0031294 |
15 |
0.012
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.012
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.012
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.012
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.012
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.012
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.012
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.012
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.011
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.011
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.011
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.011
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.011
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
14 |
0.011
|
|
|
|
cellular response to hydroperoxide
|
GO:0071447 |
4 |
0.011
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.011
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.011
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.011
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.011
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.011
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.011
|
|
|
|
positive regulation of regulated secretory pathway
|
GO:1903307 |
10 |
0.011
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.011
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.011
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.011
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.011
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.010
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.010
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.010
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.010
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.010
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.010
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.010
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.010
|
|
|
|
positive regulation of leukocyte degranulation
|
GO:0043302 |
10 |
0.010
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.010
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.010
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.010
|
|
|
|
negative regulation of vesicle fusion
|
GO:0031339 |
1 |
0.010
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.010
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.010
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.010
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.010
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.010
|
Rat |
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.010
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.010
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.010
|
|